Home Executives


Gregory Moore Appointed to Hill-Rom Board of Directors

Dr. Gregory Moore is currently the Corporate Vice President, Health Technology and Alliances at Microsoft Corporation.

Axel Schleyer, Ph.D. Appointed Chief Executive Officer of Aragen Bioscience

Aragen Bioscience Inc. Aragen, is a wholly-owned subsidiary of GVK BIO, is a leading Contract Research Organization focused on accelerating biologicals product development with an integrated offering that includes antibody discovery and humanization, stable cell line development, recombinant protein production and purification, and differentiated diseases models.

Ronald Murphy Named New CEO of Theromics Inc. and Dr. Joseph Amaral Appointed to Board of Directors

Theromics Inc., a recently formed medical device company pioneering novel technologies for interventional oncology, has announced the appointment of Ron Murphy as their new CEO. Ron will assume responsibilities on April 18, 2019 and will succeed Thomas Ryan.

Radiance Therapeutics, Inc. Expands Leadership Team: Abigail Mackrill and James Fazio, MBA, Msc Eng. Join the Team

Abigail Mackrill, formerly of Ophthalmology Futures Forums and The Ophthalmologist, joins as Director of Business Development and Outreach. In addition, James Fazio, MBA, Msc Eng, formerly Global Business Leader for Gore Medical’s Peripheral Vascular business unit, will now serve as Director of Engineering at RadianceTx®. Cassie Vollmer, Director of Quality Assurance and Regulatory Affairs, joins RadianceTx® from Vyaire Medical.

Bud Reeves Named VP of Electromed

Bud Reeves has over 20 years of sales and marketing leadership experience in the healthcare industry and brings a history of strong execution of growth strategies and proven results, specifically in emerging respiratory markets.

Timothy Stonesifer Appointed CFO of Alcon

4/2/19: Timothy Stonesifer is a seasoned executive who joins Alcon with over 29 years of global financial and operational experience. He was most recently with Hewlett Packard Enterprises (HPE), where he served as Executive Vice President and CFO.

GT Biopharma Completes Management Restructuring

3/26/19: Anthony J Cataldo has been named Chairman and Chief Executive Officer of GT Biopharma. Mr. Cataldo founded and served as Chairman and Chief Executive Officer at Iovance Biotherapeutics, Inc. He created Iovance with assets purchased from the National Cancer Institute (NCI).

John Bolla Promoted to COO, a Newly Created Position at Lantheus Holdings

3/25/19: Prior to joining Lantheus in May 2018, John Bolla spent 20 years at GlaxoSmithKline plc (GSK), a global branded pharmaceutical company. He held various senior leadership roles at GSK, including Vice President, Supply Chain, North America, where he was responsible for leading all manufacturing, supply planning, logistics and distribution for GSK’s largest global market.

Cesare Orlandi, M.D. CMO Lantheus To Retire Effective September 2

3/25/19: Dr. Orlandi will be employed by the Company in a full time capacity until his retirement date, and will continue in his role as Chief Medical Officer until his successor is appointed.

Mitchell Levinson Appointed to Pulse Biosciences Board of Directors

3/19/19: Levinson, 58, has more than 25 years of experience bringing novel medical technologies to the market, including over a decade in the aesthetics procedure market.

Sandra Clarke, CPA, CMA Appointed CFO of Synaptive Medical

3/19/19: Ms. Clarke joins Synaptive Medical with decades of experience in financial management and operations, having led a variety of small-to-mid-sized companies.

Robert Richard, Ph.D. Appointed Vice President of Research and Development at Anika Therapeutics

3/19/19: Dr. Richard is a 20-year research and development (R&D) veteran bringing extensive leadership and product development experience in orthopedic and regenerative medicine.

Trui Hebbelinck Appointed Chief Human Resources Officer of LivaNova

3/19/19: Hebbelinck’s career spans more than 20 years in healthcare, financial services and energy.

CardioMech Expands Mitral Leadership Team

3/19/19: “I am extremely pleased to announce this expansion of CardioMech’s mitral leadership team with the addition of four experienced medical technology professionals,” said Rick Nehm, President and CEO of CardioMech.

Jim O’Connor Named General Counsel and Senior Vice President, Strategic Development Announces Renovia

3/14/19: Mr. O’Connor joined Renovia as General Counsel in February 2018 and since then has led the company’s legal, compliance, quality and regulatory functions.

Board of Directors of Medtronic Appoints Andrea J. Goldsmith, Ph.D. as a New Director

3/14/19: Dr. Goldsmith is the Stephen Harris professor in the School of Engineering at Stanford University and director of Stanford's Wireless Systems Laboratory.

Francine R. Kaufman, M.D New Chief Medical Officer of Senseonics

3/6/19: Francine R. Kaufman’s career spans almost 40 years in diabetes care. She is a dedicated pediatric endocrinologist and has served as director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles.

Barry Keenan Appointed Vice President of Engineering of BioSig Technologies

3/6/19: Dr. Keenan brings to the Company over 20 years of experience in R&D, product development and commercialization and deep industry expertise in a range of sectors, including neuromodulation, deep brain stimulation, sensing, imaging and cardiac pacing.

UCB Ventures Appoints Alicia Irurzun-Lafitte as Partner

3/6/19: Alicia Irurzun-Lafitte brings 10 years of deal making experience, spanning business development transactions to early stage investments in biotech.

Cathy Barr Joins Pelvital USA, Inc. Board of Directors

3/6/19: “Pelvic Floor Dysfunction, and specifically stress urinary incontinence, is an unmet clinical need affecting millions of women. From what I’ve seen from the clinical results, Pelvital’s technology holds great promise to provide a solution to most women who suffer from this condition,” Barr said. “I am very pleased to be joining the Pelvital Board and to help bring this new technology to patients.”

Cerus Corporation Announces Appointment of Jami Nachtsheim to Board of Directors

3/5/19: Ms. Nachtsheim currently serves on the Board at Intuitive Surgical, the global market leader in robotic-assisted minimally invasive surgical systems. Ms. Nachtsheim brings nearly four decades of commercial and marketing leadership experience to the Cerus Board.

Must Read

LifeSPARC Advanced Circulatory Support System

“LifeSPARC is the new generation pump and controller for the venerable Tandem system – a small but powerful heart pump with a magnetic bearing, a low-profile controller and a highly simplified user interface. I believe many more patients will have access to this higher level of support for the first time,” said Dr. David Baran, System Director for Advanced Heart Failure Transplant and Mechanical Circulatory Support at Sentara Heart Hospital in Norfolk, Va.

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

“SIRONA II builds on the success of our First-in-Human trial and expands our experience with the Cordella Sensor as we progress towards receiving our CE Mark,” stated Katrin Leadley, MD, Chief Medical Officer of Endotronix.

Joe Montana Professional Football Hall of Famer Joins Stimwave Technologies As Official Spokesperson

“After years of dealing with the residual effects of my professional football career, I am excited to have found this battery-free, minimally-invasive alternative to opioids that relieves chronic pain and I’m eager to help other chronic pain sufferers receive this life-changing micro-implant,” said Montana.